156 related articles for article (PubMed ID: 9508726)
1. Topological nuts and bolts.
Nash HA
Science; 1998 Mar; 279(5356):1490-1. PubMed ID: 9508726
[No Abstract] [Full Text] [Related]
2. Structural insights into the function of type IB topoisomerases.
Redinbo MR; Champoux JJ; Hol WG
Curr Opin Struct Biol; 1999 Feb; 9(1):29-36. PubMed ID: 10047584
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.
Redinbo MR; Stewart L; Kuhn P; Champoux JJ; Hol WG
Science; 1998 Mar; 279(5356):1504-13. PubMed ID: 9488644
[TBL] [Abstract][Full Text] [Related]
4. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
Champoux JJ
Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
[TBL] [Abstract][Full Text] [Related]
5. Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.
Ivanova B; Spiteller M
Biopolymers; 2012 Feb; 97(2):134-44. PubMed ID: 21898362
[TBL] [Abstract][Full Text] [Related]
6. Role of flexibility and long range communication on the function of human topoisomerase I.
Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
[TBL] [Abstract][Full Text] [Related]
7. DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.
Feofanov AV; Baranov AV; Fleury F; Riou JF; Nabiev IR; Manfait M
FEBS Lett; 1996 Nov; 396(2-3):289-92. PubMed ID: 8915005
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for specificity in the poxvirus topoisomerase.
Perry K; Hwang Y; Bushman FD; Van Duyne GD
Mol Cell; 2006 Aug; 23(3):343-54. PubMed ID: 16885024
[TBL] [Abstract][Full Text] [Related]
9. Type IA DNA topoisomerases: strictly one step at a time.
Champoux JJ
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):11998-2000. PubMed ID: 12221296
[No Abstract] [Full Text] [Related]
10. Enzymes that push DNA around.
Keck JL; Berger JM
Nat Struct Biol; 1999 Oct; 6(10):900-2. PubMed ID: 10504717
[TBL] [Abstract][Full Text] [Related]
11. Differences in the topoisomerase I cleavage complexes formed by camptothecin and wakayin, a DNA-intercalating marine natural product.
Kokoshka JM; Capson TL; Holden JA; Ireland CM; Barrows LR
Anticancer Drugs; 1996 Sep; 7(7):758-65. PubMed ID: 8949987
[TBL] [Abstract][Full Text] [Related]
12. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of type IA topoisomerase-mediated DNA topological transformations.
Li Z; Mondragón A; DiGate RJ
Mol Cell; 2001 Feb; 7(2):301-7. PubMed ID: 11239459
[TBL] [Abstract][Full Text] [Related]
14. The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance.
Wang Z; D'Annessa I; Tesauro C; Ottaviani A; Soren BC; Dasari JB; Messina B; Thareparambil A; Fiorani P
Arch Biochem Biophys; 2019 Mar; 663():165-172. PubMed ID: 30653963
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives.
Laco GS
PLoS One; 2011; 6(8):e24314. PubMed ID: 21912628
[TBL] [Abstract][Full Text] [Related]
16. Rapid chromatin reorganization induced by topoisomerase I-mediated DNA damage.
Sun M; Duann P; Lin CT; Zhang H; Liu LF
Ann N Y Acad Sci; 2000; 922():340-2. PubMed ID: 11193917
[No Abstract] [Full Text] [Related]
17. Identification of a minimal functional linker in human topoisomerase I by domain swapping with Cre recombinase.
Frøhlich RF; Juul S; Nielsen MB; Vinther M; Veigaard C; Hede MS; Andersen FF
Biochemistry; 2008 Jul; 47(27):7127-36. PubMed ID: 18553933
[TBL] [Abstract][Full Text] [Related]
18. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
Streltsov SA
J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
[TBL] [Abstract][Full Text] [Related]
19. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.
Kerrigan JE; Pilch DS
Biochemistry; 2001 Aug; 40(33):9792-8. PubMed ID: 11502172
[TBL] [Abstract][Full Text] [Related]
20. DNA manipulators: caught in the act.
Changela A; Perry K; Taneja B; Mondragón A
Curr Opin Struct Biol; 2003 Feb; 13(1):15-22. PubMed ID: 12581655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
